MARKET

MBCOF

MBCOF

Marvel Biosciences Corp
OTCMQB
0.111
-0.004
-3.23%
Closed 09:30 02/12 EST
OPEN
0.111
PREV CLOSE
0.114
HIGH
0.111
LOW
0.111
VOLUME
5.00K
TURNOVER
554
52 WEEK HIGH
0.241
52 WEEK LOW
0.060
MARKET CAP
6.42M
P/E (TTM)
-3.4486
1D
5D
1M
3M
1Y
5Y
1D
Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204
Newsfile · 02/03 21:30
Marvel Biosciences Announces Grant of Deferred Share Units
Newsfile · 11/10/2025 22:15
Marvel Biosciences Announces Acceleration of Warrant Expiry Date
Newsfile · 10/03/2025 09:00
Weekly Report: what happened at MBCOF last week (0908-0912)?
Weekly Report · 09/15/2025 11:32
Weekly Report: what happened at MBCOF last week (0901-0905)?
Weekly Report · 09/08/2025 11:34
Weekly Report: what happened at MBCOF last week (0825-0829)?
Weekly Report · 09/01/2025 11:28
Weekly Report: what happened at MBCOF last week (0818-0822)?
Weekly Report · 08/25/2025 11:41
Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204
Newsfile · 08/18/2025 21:05
More
About MBCOF
Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The Company's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The Company is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.

Webull offers Marvel Biosciences Corp stock information, including OTCMQB: MBCOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBCOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBCOF stock methods without spending real money on the virtual paper trading platform.